Initial experience of using G-CSF only for autologous stem cell mobilization in patients with multiple myeloma

被引：0
|
作者：
Putkonen, M. P. [1 ]
Remes, K. R. [1 ]
Kauppila, M. K. [1 ]
Salmenniemi, U. S. [1 ]
Itala-Remes, M. I-R [1 ]
机构：
[1] Turku Univ Hosp, FIN-20520 Turku, Finland
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S545 / S545
页数：1
相关论文
共 50 条
  • [21] AUTOLOGOUS HEMATOPOIETIC STEM CELL MOBILIZATION USING CHEMOTHERAPY PLUS G-CSF VS. G-CSF ONLY: COMPARISON OF SAFETY, EFFICACY AND PRODUCT QUALITY
    Dill, V.
    Bluem, P.
    Lindemann, A.
    Manske, K.
    Hoegner, M.
    Bassermann, F.
    Hildebrandt, M.
    CYTOTHERAPY, 2024, 26 (06) : S95 - S95
  • [22] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    E Kaul
    G Shah
    C Chaulagain
    R L Comenzo
    Bone Marrow Transplantation, 2014, 49 : 1233 - 1233
  • [23] G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety and cost analysis
    A Antar
    Z K Otrock
    M A Kharfan-Dabaja
    H A Ghaddara
    N Kreidieh
    R Mahfouz
    A Bazarbachi
    Bone Marrow Transplantation, 2015, 50 : 813 - 817
  • [24] G-CSF plus preemptive plerixafor vs hyperfractionated CY plus G-CSF for autologous stem cell mobilization in multiple myeloma: effectiveness, safety and cost analysis
    Antar, A.
    Otrock, Z. K.
    Kharfan-Dabaja, M. A.
    Ghaddara, H. A.
    Kreidieh, N.
    Mahfouz, R.
    Bazarbachi, A.
    BONE MARROW TRANSPLANTATION, 2015, 50 (06) : 813 - 817
  • [25] COST-EFFECTIVENESS ANALYSIS OF MOTIXAFORTIDE ON TOP OF G-CSF FOR STEM CELL MOBILIZATION FOR AUTOLOGOUS BONE MARROW TRANSPLANTATION IN PATIENTS WITH MULTIPLE MYELOMA
    Lamotte, M.
    DiPersio, J. F.
    Siegel, D. S.
    Meron, H.
    Serlin, P. A.
    Gerlier, L.
    VALUE IN HEALTH, 2022, 25 (07) : S346 - S346
  • [26] High Efficacy of Stem Cell Mobilization With Etoposide plus Cytarabine Plus G-CSF in Patients With Multiple Myeloma
    Zhu, Zhijuan
    Li, Xiaofan
    Liu, Yiping
    Chen, Ping
    Chen, Xianling
    Li, Hua
    Huang, Jiafu
    Chen, Yuanzhong
    Li, Nainong
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [27] Stem cell mobilization in multiple myeloma patients: do we need to increase the G-CSF dose for the elderly?
    Fietz, T
    Rieger, K
    Blau, I
    Thiel, E
    Knauf, W
    BONE MARROW TRANSPLANTATION, 2003, 31 : S85 - S86
  • [28] Cytarabine plus G-CSF is more effective than cyclophosphamide plus G-CSF as a stem cell mobilization regimen in multiple myeloma
    Jelinek, Tomas
    Adamusova, Lucie
    Popkova, Tereza
    Tvrda, Ivana
    Smejkalova, Jana
    Simicek, Michal
    Salounova, Dana
    Kascak, Michal
    Mihalyova, Jana
    Plonkova, Hana
    Duras, Juraj
    Navratil, Milan
    Hajek, Roman
    Koristek, Zdenek
    BONE MARROW TRANSPLANTATION, 2019, 54 (07) : 1107 - 1114
  • [29] Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilized grafts
    Shah, Harsh
    Kim, Seongho
    Singh, Paramveer
    Alavi, Asif
    Ratanatharathorn, Voravit
    Ayash, Lois
    Uberti, Joseph
    Deol, Abhinav
    AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (02) : 198 - 204
  • [30] Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone
    Sung, A. D.
    Grima, D. T.
    Bernard, L. M.
    Brown, S.
    Carrum, G.
    Holmberg, L.
    Horwitz, M. E.
    Liesveld, J. L.
    Kanda, J.
    McClune, B.
    Shaughnessy, P.
    Tricot, G. J.
    Chao, N. J.
    BONE MARROW TRANSPLANTATION, 2013, 48 (11) : 1444 - 1449
12345